Explore more publications!

Health Network San Marino: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Network San Marino.

Press releases published on April 20, 2026

CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering
Spectral AI Announces Annual Meeting of Stockholders
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
Regeneron Announces Investor Conference Presentations
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
Amwell® to report first quarter 2026 operating results
Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Clearmind Medicine Welcomes  President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care
FibroBiologics Compliant with All Nasdaq Listing Requirements
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
NADP appoints first dentist to lead dental informatics program
KFSH se une al C3 Davos of Healthcare™ 2026 en Sunnyvale, California, como socio estratégico global
KFSH Participa da C3 Davos of Healthcare™ 2026 em Sunnyvale, Califórnia, como Parceira Estratégica Global
AB Science : Nouvelle publication sur medrxiv démontrant des bénéfices substantiels en termes de survie et de qualité de vie préservée avec le masitinib chez les patients atteints de SLA

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions